Federated Hermes Inc. Sells 10,153 Shares of Agilent Technologies, Inc. $A

Federated Hermes Inc. lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 82.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,128 shares of the medical research company’s stock after selling 10,153 shares during the period. Federated Hermes Inc.’s holdings in Agilent Technologies were worth $273,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in A. Phoenix Financial Ltd. raised its holdings in shares of Agilent Technologies by 5.7% during the third quarter. Phoenix Financial Ltd. now owns 4,597 shares of the medical research company’s stock valued at $590,000 after purchasing an additional 247 shares during the last quarter. KPP Advisory Services LLC boosted its holdings in Agilent Technologies by 3.0% in the third quarter. KPP Advisory Services LLC now owns 3,853 shares of the medical research company’s stock worth $495,000 after purchasing an additional 112 shares during the last quarter. Clark Financial Services Group Inc. BD grew its position in Agilent Technologies by 16.8% in the 3rd quarter. Clark Financial Services Group Inc. BD now owns 2,805 shares of the medical research company’s stock worth $360,000 after purchasing an additional 404 shares during the period. B. Riley Wealth Advisors Inc. raised its stake in Agilent Technologies by 8.0% during the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 2,792 shares of the medical research company’s stock valued at $358,000 after buying an additional 207 shares during the last quarter. Finally, Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Agilent Technologies by 5.7% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 40,861 shares of the medical research company’s stock valued at $5,245,000 after buying an additional 2,201 shares during the period. 87.41% of the stock is currently owned by institutional investors.

Agilent Technologies Price Performance

NYSE A opened at $129.76 on Monday. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27. The stock has a market cap of $36.79 billion, a price-to-earnings ratio of 28.39, a PEG ratio of 3.76 and a beta of 1.30. The company’s 50 day moving average is $139.96 and its two-hundred day moving average is $135.26.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company’s revenue was up 9.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th were issued a dividend of $0.255 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, January 6th. Agilent Technologies’s payout ratio is 22.32%.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the transaction, the chief executive officer directly owned 33,448 shares in the company, valued at $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the sale, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This represents a 8.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 16,401 shares of company stock worth $2,468,962 over the last 90 days. Company insiders own 0.26% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. The Goldman Sachs Group initiated coverage on Agilent Technologies in a report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective for the company. UBS Group boosted their price target on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. Barclays raised shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price target for the company in a research report on Monday, December 15th. Wells Fargo & Company raised their price objective on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, Bank of America upped their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $164.50.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.